This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 2020-2021.
Company Filing History:
Years Active: 2020-2021
Title: Yuki Kawano: Innovator in Polymer Derivatives
Introduction
Yuki Kawano is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of polymer derivatives, particularly in the development of drug delivery systems. His innovative work focuses on enhancing the effectiveness of pharmacological substances through advanced polymeric micelles.
Latest Patents
Kawano holds 2 patents that showcase his expertise in this area. His latest patents include an "Active-targeting-type polymer derivative, composition containing said polymer derivative, and uses of said polymer derivative and said composition." This invention provides a polymeric micelle type DDS preparation that efficiently exhibits pharmacological activity effects by enhancing migration characteristics, penetrability, and retention characteristics toward diseased target tissues such as tumor or inflammation-affected tissues. Another notable patent is for "Polymer derivatives, and novel polymer derivative imaging probe using same." This invention features a block copolymer that enhances imaging of tumor interiors compared to known block copolymers, thereby improving penetrability into diseased target tissues.
Career Highlights
Kawano is associated with Nippon Kayaku Kabushiki Kaisha, a company known for its innovative approaches in pharmaceuticals and chemicals. His work at this organization has allowed him to push the boundaries of polymer science and its applications in medicine.
Collaborations
Some of his notable coworkers include Keiichirou Yamamoto and Dai Kurihara, who contribute to the collaborative environment that fosters innovation within their projects.
Conclusion
Yuki Kawano's contributions to the field of polymer derivatives and drug delivery systems highlight his role as a leading inventor in Japan. His patents reflect a commitment to advancing medical technology and improving treatment outcomes for patients.